Overall rank by patents
#14,822
of 50,000 tracked assignees
USPTO PatentsView assignee record - 20 granted patents across 14 technology areas, recorded in grant years 2020–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
According to USPTO PatentsView, Novasignal ranks #14,822 of 50,000 tracked US assignees by granted-patent volume, with 20 patents across 14 technology areas.
USPTO PatentsView assignee plate
Corpus R14822 · US Corporation #14,822 · 20 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Nocion Therapeutics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Novasignal · this assignee
51 score
3D Lighting Innovati… · lowest
7 score
What this shows Novasignal Corp. stamps GRANTS-SMALL, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-USCORP, SPAN-YRS, BOOK-RICH. Volume places it #14,822 of 50,000; Innovation Score 50.9/100 sits in the top 12% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Nocion Therapeutics, Inc. (±0 grants).
Novasignal Corp. has been granted 20 US utility patents between 2020 and 2023, placing Novasignal Corp. at #14,822 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.4 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Novasignal Corp. is one of the more focused assignees in the PatentsView dataset. By volume, Novasignal sits between Nocion Therapeutics, Inc. (20 patents, rank #14,815) and ONE TEST Systems (20 patents, rank #14,823) - the closest US assignees by grant volume. The composite Innovation Score of 50.9/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Historical data spans 2020 through 2023, with 20 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Novasignal Corp.'s 19.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 14 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Nocion Therapeutics, Inc.
20 patents
Norsk Titanium AS
20 patents
Norwood Architecture, Inc.
20 patents
Nova Southeastern University
20 patents
Nuseed Pty Ltd
20 patents
OCLU LIMITED
20 patents
ONDAVIA, INC.
20 patents
ONE TEST SYSTEMS
20 patents
NovaSignal Corp.
20 patents
What this shows Novasignal holds 20 patents at rank #14,819, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #14,819 in granted patent volume.
Other assignees with the most granted patents in Novasignal's primary technology class.
Novasignal's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 5.0% |
| 2021 | 5 | 25.0% |
| 2022 | 6 | 30.0% |
| 2023 | 8 | 40.0% |
Top 14 of 14 technology areas
Overall rank by patents
#14,822
of 50,000 tracked assignees
50.9 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.